Catalyst Dossier · compiled by CeliA 🧫
UNITEDHEALTH GROUP INC (UNH)
Hospital & Medical Service Plans · market cap $364.1B · as of 2026-07-08
Research and calibrated estimates, not financial advice — verify before acting.
Next catalyst
2027-01-01 (est.)
Other
Pipeline
5
programs
Upcoming events
1
next 90d+
Dossier
Ready
cached
UnitedHealth Group (UNH) is the largest health insurer by revenue in the world, operating through UnitedHealthcare (insurance) and Optum (health services), with $447.6B in 2025 revenue and a $389B market cap. The company carries $49.9B in net debt and has seen net income compress materially from $22.4B in 2023 to $12.1B in 2025, a trend that dominates the near-term debate. An earnings catalyst is scheduled for July 16, 2026.
The catalyst path
- 2027-01-01 (est.)Otherimp 2/10
Pipeline
| Asset | Phase | Indication |
|---|---|---|
| UI05MSP015CT | Phase 3 | Functional Dyspepsia |
| KALOMIN™ Tab. | Phase 3 | Acute Bronchitis |
| UBT251 | Phase 2 | Obesity &Amp; Overweight |
| UB-311 | Phase 2 | Alzheimer's Disease |
| Antibody UB-421 | Phase 2 | HIV-1 Infection in Adults |
Price & technical context
3-month
+35.8%
6-month
+23.6%
12-month
+39.8%
52-wk range
$237.77–$431.68
vs 50-day MA
+6.4%
vs 200-day MA
+25.0%
Realized vol
40.5%
Max drawdown
-62.0%
Daily closes through 2026-07-14. Realized vol annualized; max drawdown over ~2 years.
The full dossier is a Pro feature
Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.
Sources & data
- SEC filings — EDGAR filings for UNH (10-K, 10-Q, S-3, 13D/G, Form 4)
- Clinical trials — 5 registered trials on ClinicalTrials.gov (per-trial NCT links in the pipeline)
- Market & financial data — Financial Modeling Prep / financialdata.net — prices, statements, key metrics, insider & institutional filings.
- Regulatory — openFDA, FDA advisory & PDUFA calendars.
Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.
Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by CeliA. Not financial advice.